Wide-necked bifurcation aneurysms (WNBAs) make up 26–36% of all brain aneurysms. Treatments for WNBAs pose unique challenges due to the need to preserve major bifurcation vessels while achieving a ...

This May, the World Health Assembly (WHA) will vote on re-establishing a mandate for the WHO to address the health consequences of nuclear weapons and war.1 Health professionals and their associations ...

Objective Our study aims to introduce a novel interventional treatment strategy for the management of chronic occlusion of the internal carotid artery (CO-ICA) using a specially designed thrombectomy ...

Background One-year and 3-year outcomes for the SCENT trial have previously been reported. However, 5-year (long-term) clinical outcomes have not previously been described. Methods In this multicenter ...

Background Cerebrospinal fluid (CSF) loss in spontaneous intracranial hypotension (SIH) is accompanied by volume shifts between the intracranial compartments. This study investigated tricompartimental ...

Mallinckrodt Institute of Radiology, Washington University School of Medicine, St Louis, Missouri, USA Correspondence to Dr A P Kansagra, Mallinckrodt Institute of Radiology, Washington University ...

Department of Orthopedic Surgery, Kagoshima Graduate School of Medical and Dental Sciences, Kagoshima, Japan Correspondence to Dr K Tofuku, Department of Orthopedic Surgery, Kagoshima Graduate School ...

Correspondence to Dr Adel M Malek, Department of Neurosurgery, Tufts Medical Center, 800 Washington Street, Boston, MA 02111, USA; amalek{at}tuftsmedicalcenter.org Objective Aneurysm formation in ...

Correspondence to Dr Benjamin Gory, Department of Diagnostic and Therapeutic Neuroradiology, CHRU-Nancy, Hôpital Central, 54000 Nancy, France; benjagory{at}gmail.com Background Endovascular therapy ...

The pediatric population spans a diverse age group,1 from neonates and infants to adult-sized teenagers, each with unique physiological characteristics that must be considered when performing ...

Background Flow diverters offer a promising treatment for cerebral aneurysms. However, they have associated thromboembolic risks, mandating chronic dual antiplatelet therapy (DAPT). Shield Technology ...